Tumor Regression Following Engineered Polyomavirus-Specific T Cell Therapy in Immune Checkpoint Inhibitor-Refractory Merkel Cell Carcinoma.
Asano Y, Veatch J, McAfee M, Bakhtiari J, Lee B, Martin L, Zhang S, Mazziotta F, Paulson KG, Schmitt TM, Munkbhat A, Young C, Seaton B, Hunter D, Horst N, Lindberg M, Miller N, Stone M, Bielas J, Koelle D, Voillet V, Gottardo R, Gooley T, Oda S, Greenberg PD, Nghiem P, Chapuis AG.
Asano Y, et al. Among authors: mazziotta f.
medRxiv [Preprint]. 2024 Jul 5:2024.07.01.24309780. doi: 10.1101/2024.07.01.24309780.
medRxiv. 2024.
PMID: 39006423
Free PMC article.
Preprint.